“My concern is that we make this broad-sweeping assumption that if people survive the overdose they’re okay,” said Tara Gomes, a scientist at St. Michael’s who was one of the authors of the Ontario study on infections. “It’s not enough just to think the overdose is reversed and they’re just back to where they were before.”
We are likely entering a golden era of drug innovation, with the rise of new drug development technologies and biologics, states Mina Tadrous, Tara Gomes and Michael Law in this op-ed.
The number of First Nations people who died from opioid-related deaths in Ontario more than doubled during the first year of the COVID-19 pandemic. That’s one of the key findings of a report released by the Chiefs of Ontario and the Ontario Drug Policy Research Network on Friday.
ADHD medications are increasingly being prescribed to older adults, and they may cause a short-term spike in the risk of heart attack, stroke and arrhythmias, a large new study suggests.
“We need urgent action from all levels of government. There is a need for local, provincial and federal governments to work together on this,” said Dr. Tara Gomes, a Toronto epidemiologist and the lead principal investigator of the Ontario Drug Policy Research Network.
August 20, 2021 | The Intelligencer | News Article
A new study examining the impact of the ongoing opioid crisis in Ontario has found that, on average, six people a day died from opioid overdoses during the first six months of the COVID-19 pandemic.
Ontario’s opioid crisis has worsened dramatically during the pandemic, with the homeless population and those who were unemployed accounting for a significant portion of fatal overdoses, a new report has found.
The use of benzodiazepines, prescribed for sleep and anxiety disorders, has declined in Ontario but risen for young women, study says
While overall prescriptions for benzodiazepines in Ontario fell 13 per cent between 2013 and 2019, the report revealed prescriptions for women aged 19 to 24 have risen by 30 per cent in that same timeframe